FDA Approves Bristol Myers, Pfizer's Anti-Clotting Drug Eliquis

29.12.2012 - U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb and Pfizer, for treatment in patients with atrial fibrillation, or irregular...